Crystal structure, antibacterial and cytotoxic activities of a new complex of Bismuth(III) with sulfapyridine

Molecules

Volumn 18, Issue 2, 2013, Pages 1464-1476

  Marzano, Ivana M ^a   Franco, Marina S ^a   Silva, Priscila P ^a   Augusti, Rodinei ^a   Santos, Geandson C ^a   Fernandes, Nelson G ^a   Bucciarelli Rodriguez, Mônica ^a   Chartone Souza, Edmar ^a   Pereira Maia, Elene C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antimicrobial activity; Bi(III) complex; Cytotoxic activity; Sulfapyridine; X ray structure

Indexed keywords

ANTIINFECTIVE AGENT; BISMUTH; SULFAPYRIDINE;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN K 562; CHEMISTRY; CONFORMATION; DRUG EFFECT; HUMAN; HYDROGEN BOND; MICROBIAL SENSITIVITY TEST; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; BISMUTH; CELL DEATH; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; K562 CELLS; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; SULFAPYRIDINE;

MLCS; MLOWN;

EID: 84874594680     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18021464     Document Type: Article

References (46)

1. Payne, D.J. Desperately Seeking New Antibiotics. Science 2008, 321, 1644-1645.
2. Davies, J.; Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417-433.
3. Silver, L.L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 2011, 24, 71-109.
4. Brown, G.M. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J. Biol. Chem. 1962, 237, 536-540.
5. Huovinen, P.; Sundström, L.; Swedberg, G.; Sköld, O. Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother. 1995, 39, 279-289.
6. Yang, N.; Sun, H. Biocoordination chemistry of bismuth: Recent advances. Coord. Chem. Rev. 2007, 251, 2354-2366.
7. Ford, A.C.; Malfertheiner, P.; Giguere, M.; Santana, J.; Khan, M.; Moayyedi, P. Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis. World J. Gastroenterol. 2008, 14, 7361-7370.
8. Dore, M.P.; Farina, V.; Cuccu, M.; Mameli, L.; Massarelli, G.; Graham, D.Y. Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days. Helicobacter 2011, 16, 295-300.
9. O'Connor, A.; Gisbert, J.P.; McNamara, D.; O'Morain, C. Treatment of Helicobacter pylori Infection 2010. Helicobacter 2010, 15, 46-52.
10. Rimbara, E.; Fischbach, L.A.; Graham, D.Y. Optimal therapy for Helicobacter pylori infections. Nat. Rev. Gastroenterol. Hepatol. 2011, 8, 79-88.
11. Sun, Q.; Liang, X.; Zheng, Q.; Liu, W.; Xiao, S.; Gu, W.; Lu, H. High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication. Helicobacter 2010, 15, 233-238.
12. Thurston, J.H.; Marlier, E.M.; Whitmire, K.H. Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10- phenanthroline)(C7H8]2. Chem. Commun. 2002, 2834-2835. (Pubitemid 35375704)
13. Andrews, P.C.; Ferrero, R.L.; Junk, P.C.; Kumar, I.; Luu, Q.; Nguyen, K.; Taylor, J.W. Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori. Dalton Trans. 2010, 39, 2861-2868.
14. Turel, I.; Goli, L.; Bukovec, P.; Gubina, M. Antibacterial tests of bismuth(III)-quinolone (ciprofloxacin, cf) compounds against Helicobacter pylori and some other bacteria. Crystal structure of (cfH2)2[Bi2Cl10]4H2O. J. Inorg. Biochem. 1998, 71, 53-60. (Pubitemid 28460821)
15. Turel, I.; Leban, I.; Bukovec, N. Crystal structure and characterization of the bismuth(III) compound with quinolone family member (Ciprofloxacin). Antibacterial study. J. Inorg. Biochem. 1997, 66, 241-245. (Pubitemid 27213223)
16. Diemer, R.; Dittes, U.; Nuber, B.; Seifried, V.; Opferkuch, W.; Keppler, B.K. Synthesis, characterization and molecular structures of some bismuth(III) complexes with thiosemicarbazones and dithiocarbazonic acid methylester derivatives with activity against Helicobacter Pylori. Met. Based Drugs 1995, 2, 271-292.
17. Nomiya, K.; Sekino, K.; Ishikawa, M.; Honda, A.; Yokoyama, M.; Kasuga, N.C.; Yokoyama, H.; Nakano, S.; Onodera, K. Syntheses, crystal structures and antimicrobial activities of monomeric 8-coordinate, and dimeric and monomeric 7-coordinate bismuth(III) complexes with tridentate and pentadentate thiosemicarbazones and pentadentate semicarbazone ligands. J. Inorg. Biochem. 2004, 98, 601-615. (Pubitemid 38369289)
18. Li, M.; Lu, Y.; Yang, M.; Li, Y.; Zhang, L.; Xie, S. One dodecahedral bismuth(III) complex derived from 2-acetylpyridine N(4)- pyridylthiosemicarbazone: Synthesis, crystal structure and biological evaluation. Dalton Trans. 2012, 41, 12882-12887.
19. Li, M.; Yang, M.; Niu, J.; Zhang, L.; Xie, S. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis(4N-methylthiosemicarbazone): Crystal structure and both in vitro and in vivo biological evaluation. Inorg. Chem. 2012, 51, 12521-12526.
20. Li, M.; Zhang, L.; Yang, M.; Niu, J.; Zhou, J. Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N(4)-phenylthiosemicarbazone. Bioorg. Med. Chem. Lett. 2012, 22, 2418-2423.
21. Zhang, L.; An, G.; Yang, M.; Li, M.; Zhu, X. Synthesis, characterization, crystal structure and biological activities of the unusual main group 8-coordinate bismuth (III) complex derived from 2-acetylpyrazine N4- pyridylthiosemicarbazone. Inorg. Chem. Commun. 2012, 20, 37-40.
22. Domenico, P.; Salo, R.J.; Novick, S.G.; Schoch, P.E.; van Horn, K.; Cunha, B.A. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators. Antimicrob. Agents Chemother. 1997, 41, 1697-1703. (Pubitemid 27339870)
23. Andrews, P.C.; Busse, M.; Deacon, G.B.; Ferrero, R.L.; Junk, P.C.; MacLellan, J.G.; Vom, A. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori. Dalton Trans. 2012, 41, 11798-11806.
24. Ge, R.; Sun, X.; Gu, Q.; Watt, R.M.; Tanner, J.A.; Wong, B.C.; Xia, H.H.; Huang, J.D.; He, Q.Y.; Sun, H. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori. J. Biol. Inorg. Chem. 2007, 12, 831-842. (Pubitemid 47174873)
25. Chen, Z.; Zhou, Q.; Ge, R. Inhibition of fumarase by bismuth(III): Implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori. Biometals 2012, 25, 95-102.
26. Guerra, W.; Silva, I.R.; Azevedo, E.A.; Monteiro, A.R.S.; Bucciarelli-Rodriguez, M.; Chartone-Souza, E.; Silveira, J.N.; Fontes, A.P.S.; Pereira-Maia, E.C. Three New Complexes of Platinum(II) with Doxycycline, Oxytetracycline and Chlortetracycline and their Antimicrobial Activity. J. Braz. Chem. Soc. 2006, 17, 1627-1633.
27. Guerra, W.; Azevedo, E.A.; Monteiro, A.R.S.; Bucciarelli-Rodriguez, M.; Chartone-Souza, E.; Nascimento, A.M.A.; Fontes, A.P.S.; le Moyec, L.; Pereira-Maia, E.C. Synthesis, characterization, and antibacterial activity of three palladium(II) complexes of tetracyclines. J. Inorg. Biochem. 2005, 99, 2348-2354. (Pubitemid 41727924)
28. Chartone-Souza, E.; Loyola, T.L.; Bucciarelli-Rodriguez, M.; Menezes, M.A.; Rey, N.A.; Pereira-Maia, E.C. Synthesis and characterization of a tetracycline-platinum (II) complex active against resistant bacteria. J. Inorg. Biochem. 2005, 95, 1001-1008.
29. Breunig, H.J; Nema, M.G.; Silvestru, C.; Richard, A.S.; Varga, A. [2-{E(CH2CH2)2NCH2} C6H4]nBiX3-n (E = O, NMe; X = Cl, Br, I; n = 1-3) and [2-(Me2NCH2)C6H4]BiBr2 - New Hypervalent Organobismuth(III) Compounds. Z. Anorg. Allg. Chem. 2010, 636, 2378-2386.
30. Ferrari, M.B.; Cappacchi, L.C.; Calvaca, L.; Gasparri, G.F. The Crystal and Molecular Structure of Trichlorotris-(3-sulphanilamido-6-methoxypyridazine) bismuth(III). Acta Crystallogr. B 1972, 28, 1169-1173.
31. Soran, A.; Breunig, H.J.; Lippolis, V.; Arca, M.; Silvestru, C. Syntheses, solid-state structures, solution behavior of hypervalent organobismuth(III) compounds [2-(Et2NCH2)C6H4]nBiX3-n and DFT characterization of [2-(Me2NCH2)C6H4]nBiX3-n [X = Cl, Br, I; n = 1-3]. J. Organomet. Chem. 2010, 695, 850-862.
32. Geary, W.J. The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Coord. Chem. Rev. 1971, 7, 81-122.
33. Cook, D. Vibrational spectra of pyridinium salts. Can. J. Chem. 1961, 39, 2009-2024.
34. Kremer, E; Facchin, G.; Estévez, E.; Alborés, P.; Baran, E.J.; Ellena, J.; Torre, M.H. Copper complexes with heterocyclic sulfonamides: Synthesis, spectroscopic characterization, microbiological and SOD-like activities: Crystal structure of [Cu(sulfisoxazole)2(H2O)4]·2H2O. J. Inorg. Biochem. 2006, 100, 1167-1175. (Pubitemid 43833464)
35. Mondelli, M.; Bruné, V.; Borthagaray, G.; Ellena, J.; Nascimento, O.R.; Leite, C.Q.; Batista, A.A.; Torre, M.H. New Ni(II)-sulfonamide complexes: Synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4]·2H2O and [Ni(sulfapyridine)2]. J. Inorg. Biochem. 2008, 102, 285-292.
36. Macías, B.; García, I.; Villa, M.V.; Borrás, J.; Castiñeiras, A.; Sanz, F. Synthesis and characterization of sulfonamides containing 8-aminoquinoline and their Ni(II) complexes. Crystalline structures of the Ni complexes. Polyhedron 2002, 21, 1229-1234.
37. Tiekink, E.R.T. Antimony and bismuth compounds in oncology. Crit. Rev. Oncol. Hematol. 2002, 42, 217-224. (Pubitemid 34618518)
38. Li, H.; Lai, C.S.; Wu, J.; Ho, P.C.; Vos, D.; Tiekink, E.R.T. Cytotoxicity, qualitative structureactivity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes. J. Inorg. Biochem. 2007, 101, 809-816. (Pubitemid 46529003)
39. Huang, R.; Wallqvist, A.; Covell, D.G. Anticancer metal compounds in NCI's tumor-screening database: Putative mode of action. Biochem. Pharmacol. 2005, 69, 1009-1039. (Pubitemid 40349015)
40. CRYSALISPRO, Version 1.171.33.55 (release 05-01-2010 CrysAlis 171.NET). Oxford Diffraction Ltd.: Oxfordshire, UK, 2010.
41. Altomare, A.; Burla, M.C.; Camalli, M.; Cascarano, G.L.; Giacovazzo, C.; Guagliardi, A.; Moliterni, A.G.G.; Polidori, G.; Spagna, R. SIR97: A new tool for crystal structure determination and refinement. J. Appl. Crystallogr. 1999, 32, 115-119. (Pubitemid 129699322)
42. Farrugia, L.J. WinGX suite for small-molecule single-crystal crystallography. J. Appl. Crystallogr. 1999, 32, 837-838. (Pubitemid 129794704)
43. Sheldrick, G.M. SHELXL-97 - A Program for Crystal Structure Refinement; University of Goettingen: Göttingen, Germany, 1997.
44. Flack, H.D. On enantiomorph-polarity estimation. Acta Crystallogr. 1983, A39, 876-881.
45. Macrae, C.F.; Edgington, P.R.; McCabe, P.; Pidcock, E.; Shields, G.P.; Taylor, R.; Towler, M.; van de Streek, J. Mercury: Visualization and analysis of crystal structures. J. Appl. Crystallogr. 2006, 39, 453-457. (Pubitemid 43806296)
46. Weber, S. XRDIFF: Simulation of X-ray diffraction patterns. J. Appl. Crystallogr. 1997, 30, 565-566. (Pubitemid 127791757)